Evaluation of YAP as a therapeutic target in HCC and CCA

被引：0
|
作者：
Bai, Haibo [1 ,2 ]
Quy Nguyen [4 ]
Zhu, Qingfeng [3 ]
Alpini, Gianfranco [1 ,2 ,4 ]
Anders, Robert [3 ]
机构：
[1] Baylor Scott & White Healthcare, Digest Dis Res Ctr, Temple, TX USA
[2] Texas A&M Univ, Coll Med, Internal Med, Temple, TX 76508 USA
[3] Johns Hopkins Univ, Sch Med, Pathol, Baltimore, MD USA
[4] Cent Texas Vet Hlth Care Syst, Res Serv, Temple, TX USA
来源：
FASEB JOURNAL | 2015年 / 29卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
45.4
引用
收藏
页数：1
相关论文
共 50 条
  • [21] HNRNPM Regulates HCC Tumorigenesis and Cancer Stemness: Identification of a Novel Therapeutic Target?
    Kennedy, Lindsey
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2022, 13 (05): : 1471 - 1473
  • [22] Natural killer cells target XPO1: a therapeutic opportunity for HCC
    Rettman, Pauline
    Blunt, Matthew
    Bastidas-Legarda, Leidy
    Fulton, Rebecca
    Schittenhelm, Ralf
    Khakoo, Salim
    JOURNAL OF HEPATOLOGY, 2020, 73 : S647 - S648
  • [23] The Mechanism of Rac1 in Regulating HCC Cell Glycolysis Which Provides Underlying Therapeutic Target for HCC Therapy
    Ren, Yin-Xiang
    Li, Xiao-Bin
    Liu, Wei
    Yang, Xu-Guang
    Liu, Xin
    Luo, Yu
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [24] Hippo/YAP signaling pathway: a new therapeutic target for diabetes mellitus and vascular complications
    Wei, Lan
    Gao, Jingjing
    Wang, Liangzhi
    Tao, Qianru
    Tu, Chao
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2023, 14
  • [25] The SFK-YAP axis can be a new potential therapeutic target in colorectal cancer
    Taniguchi, Koji
    Kawazoe, Tetsuro
    CANCER SCIENCE, 2021, 112 : 261 - 261
  • [26] THERAPEUTIC ADVANCES IN HCC
    Sangro, Bruno
    LIVER INTERNATIONAL, 2019, 39 (12) : 2460 - 2461
  • [27] SLC1A4: A Powerful Prognostic Marker and Promising Therapeutic Target for HCC
    Peng, Xiaozhen
    Chen, Ruochan
    Cai, Shenglan
    Lu, Shanshan
    Zhang, Yiya
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [28] DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC
    Liu, Nanbin
    Zhang, Hailong
    Zhang, Chunli
    Li, Zeyu
    Huang, Limin
    Sun, Jin
    Qi, Junan
    Deng, Xi
    Huang, Na
    Mu, Yanhua
    Li, Zongfang
    Tian, Hongwei
    CANCERS, 2023, 15 (21)
  • [29] CDT1 is a Potential Therapeutic Target for the Progression of NAFLD to HCC and the Exacerbation of Cancer
    He, Xingyu
    Ma, Jun
    Yan, Xue
    Yang, Xiangyu
    Wang, Ping
    Zhang, Lijie
    Li, Na
    Shi, Zheng
    CURRENT GENOMICS, 2024,
  • [30] Significance of the Rac signaling pathway in HCC cell motility: implications for a new therapeutic target
    Lee, TK
    Man, K
    Ho, JW
    Wang, XH
    Poon, RT
    Sun, CK
    Ng, KT
    Ng, IO
    Xu, R
    Fan, ST
    CARCINOGENESIS, 2005, 26 (03) : 681 - 687
12345